ImClone Systems to Hold Conference Call Today At 2:00 PM to Discuss Commercialization Agreement...
Business Editors and Medical/Health Writers
NEW YORK--(BW HealthWire)--Sept. 19, 2001
ImClone Systems Incorporated (Nasdaq: IMCL) will host a conference call today at 2:00 pm Eastern Standard Time to discuss its agreement with Bristol-Myers Squibb to co-develop and co-promote
ImClone Systems Incorporated is committed to advancing oncology care by developing a portfolio of targeted biologic treatments, designed to address the medical needs of patients with a variety of cancers. The Company's three programs include growth factor blockers, cancer vaccines and angiogenesis inhibitors. ImClone Systems' strategy is to become a fully integrated biopharmaceutical company, taking its development programs from the research stage to the market. ImClone Systems is headquartered in New York with manufacturing facilities in Somerville, New Jersey.
Except for the historical information contained herein, the matters discussed in this news release may include forward-looking statements. Actual results may differ materially from those predicted in such forward-looking statements due to the risks and uncertainties inherent in the Company's business, including, without limitation, risks and uncertainties in obtaining and maintaining regulatory approval, market acceptance of and continuing demand for the Company's products, the impact of competitive products and pricing, and the Company's ability to obtain additional financing to support its operations. The Company undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.
In addition, make sure to read these articles:
- Random samples: sales.
- Central: Our Lab Doors Are Open
- New York Sports Clubs Opens in Carmel, New York.
- ImClone Systems Raises An Additional $3 Million.
- ImClone Systems Announces $3 Million Financing.
- IMCLONE SYSTEMS ADDS WILLIAM R. MILLER AND DAVID M. KIES TO ITS BOARD OF DIRECTORS.
- ImClone Systems to Host Teleconference and Webcast of May 13, 2001 Analyst Meeting.
- Hoffman & Edelson, LLC Announces Class Action Lawsuit Against ImClone Systems, Inc.
- ImClone Systems Announces FDA Acceptance of BB36 Manufacturing Facility CMC Supplemental...
- Milberg Weiss Announces Class Action Suit Against ImClone Systems, Inc.
- ImClone Systems Reports Second Quarter 2003 Earnings.
- Scott + Scott Files Class Action Lawsuit Against ImClone Systems, Inc. on Behalf of...
- ImClone Systems to Host 2006 First Quarter Financial Results Conference Call.
- ImClone Systems Reports 2001 Fourth Quarter and Year End Financial Results.
- ImClone Systems Appoints Peter S. Ringrose, M.A., Andrew G. Bodnar, M.D., J.D., and Peter...
Email
Digg It
del.icio.us
Business Resources
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© COPYRIGHT 2001 Business Wire
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists
AllBusiness.com, its parent company D&B, and its affiliates.
